SurgePays wins Nasdaq extension to regain $1 minimum bid price compliance by March 22, 2027

SurgePays received a Nasdaq notice granting 180 extra days, until March 22, 2027, to cure a $1.00 minimum bid-price deficiency; failure triggers a delisting notice with an appeal option that would not stay a trading suspension. Nasdaq cited a potential reverse stock split plan. A separate Nasdaq letter said the company is back in compliance with the minimum stockholders’ equity rule under Listing Rule 5550(b)(1).